Clinical Trials · NCT00002597

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Name: Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Radiation Therapy Oncology Group
Enrollment: 2,028
Start date: Oct 1994
Locations: 239 sites, United States, Canada
Primary endpoint: Overall Survival Rate (10-year)

View Gonadorelin compound reference